Status:
UNKNOWN
Acupuncture and Insulin Doses in Insulin-treated Type 2 Diabetes
Lead Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
This study is a randomized, single blinded, cross-over interventional study for evaluating the effect of acupuncture versus sham acupuncture in diabetic type 2 patient in insulin treatment. Primary en...
Eligibility Criteria
Inclusion
- type 2 Diabetes Mellitus
- insulin therapy \> 20 UI daily for at least 6 months
- HbA1c \< 69 mmol/mol
Exclusion
- Class I Psychiatric illness not adequately treated
- Actual pregnancy or breastfeeding, or pregnancy planning.
- Corticosteroid treatment
- Severe heart failure (NYHA III-IV)
- Severe renal failure (pre-dialysis o dialysis),
- Severe liver insufficiency (overt cirrhosis)
- Severe respiratory failure (oxygen therapy)
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04076800
Start Date
August 1 2019
End Date
October 31 2023
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetologia AOU Careggi
Florence, Italy, 50134